![Kevin Smith](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kevin Smith
Vorstandsvorsitzender bei
INOGEN, INC.
Vermögen: 860 830 $ am 31.07.2026
Profil
Kevin R.
M.
Smith is President, Chief Executive Officer & Director at Inogen, Inc. since 2023.
Formerly, Mr. Smith was President, CEO & Executive Director at Sirtex Medical, Inc. from 2019 to 2023, Director at OncoSec Medical, Inc. from 2022 to 2023, Global Vice President-Sales & Marketing at Teleflex, Inc. from 2008 to 2014, Executive Vice President-Business Development at Medcura, Inc. from 2017 to 2018, and Chief Commercial Officer at Sensium Healthcare Ltd. from 2015 to 2016.
Education includes undergraduate studies at the University of Kentucky and an MBA from the University of Phoenix.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
INOGEN, INC. 0.49% | 06.04.2026 | 133’462 ( 0.49% ) | 860 830 $ | 31.07.2026 |
Aktive Positionen von Kevin Smith
| Unternehmen | Position | Beginn |
|---|---|---|
| INOGEN, INC. | Vorstandsvorsitzender | 10.11.2023 |
Ehemalige bekannte Positionen von Kevin Smith
| Unternehmen | Position | Ende |
|---|---|---|
Sirtex Medical, Inc.
 Sirtex Medical, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and supplies liver cancer treatment products and therapies | Vorstandsvorsitzender | 01.11.2023 |
| ONCOSEC MEDICAL INCORPORATED | Vorstandsvorsitzender | 02.05.2022 |
Medcura, Inc.
 Medcura, Inc. Medical SpecialtiesHealth Technology Operates as a biomaterial platform that provides hemostasis technology services | Corporate Officer/Principal | 01.12.2018 |
Sensium Healthcare Ltd.
 Sensium Healthcare Ltd. Medical/Nursing ServicesHealth Services Provides health care services | Corporate Officer/Principal | 01.11.2016 |
| TELEFLEX INCORPORATED | Vertrieb & Marketing | 01.09.2014 |
Ausbildung von Kevin Smith
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
55
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Teleflex, Inc.
 Teleflex, Inc. Medical SpecialtiesHealth Technology Provides medical devices for critical care, urology and surgery | Health Technology |
Inogen, Inc.
 Inogen, Inc. Medical SpecialtiesHealth Technology Operates as a medical technology company | Health Technology |
OncoSec Medical, Inc.
 OncoSec Medical, Inc. BiotechnologyHealth Technology Engages in discovery and development of novel immunotherapeutic products for immuno-oncology treatment | Health Technology |
University of Kentucky
 University of Kentucky Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Phoenix
 University of Phoenix Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sirtex Medical, Inc.
Sirtex Medical, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and supplies liver cancer treatment products and therapies | Health Technology |
Medcura, Inc.
Medcura, Inc. Medical SpecialtiesHealth Technology Operates as a biomaterial platform that provides hemostasis technology services | Health Technology |
Sensium Healthcare Ltd.
Sensium Healthcare Ltd. Medical/Nursing ServicesHealth Services Provides health care services | Health Services |
